NOSA Drug delivery
NOSA Drug delivery is a proprietary nasal drug delivery platform for controlled administration of drugs.
The nasal plug emits the drug in gaseous form when the patient breathes through the product and enables direct uptake in the olfactory bulb as well as through the trigeminal nerve.
Thus enabling direct to brain absorption by bypassing the ”blood brain barrier”. This makes the platform relevant for a vast set of different type of molecules.
Benefits
NOSA Drug delivery enables effective drug delivery
- Increased efficacy
- Less side effects
- Patient friendly
- Cost savings
- Non invasive
Clinical validation
The product has went through excessive testing and validation and proof of concept is achieved january 2026. Technology has been proven in in-vitro as well as in-vivo trials with clinical relevant absorption in brain, lung and blood plasma. In vivo study data shows that role model substance Memantine was measured at four times higher doseage than therapeutic levels with half the recommended dose administrated.
How it works
NOSA drug delivery is a medical device that is infused with drugs as an integral part of the device. This enables the drug to be emitted in a controlled release that can be altered depending on the specific API molecule profile and pharmacokinetic preferences.
The drug is emitted in a gaseos form which enables absorption through the olfactory bulb and trigeminal nerve. Certain molecules will hence be able to cross the blood brain barrier and targeting the brain and central nerve system.
The technology
NOSA has developed the propriatary and patented technology for over 15 years and are now ready to commercialize the thechnology.
The technology is based on mixing of substances in plastic and the controlled release of the drug molecules. The technology is adapted to a wide variety of molecules and can also be adapted to adjust the doseage as well as the time of release.
Intellectual property
The Drug delivery device has a wide patent portfolio consisting of both design and function. The patent family is open to additional molecule extensions.
The manufacturing technology that enabels the function of the delivery platform is non published “know-how”.
Partnership
We partner with pharmaceutical companies through licensig agreements and are open to exclusive agreements within certain therapeutic areas.
Feel fre to contact us if you are interested in potential partnership: partnering@nosaplugs.com
NOSA Drug delivery
The future of intra nasal drug administration